FOXO4-DRI Peptide Purity Specifications and Manufacturing Sourcing Guide for Lab Formulation
Executive Summary
FOXO4-DRI peptide is a specialized research compound gaining attention in laboratory settings for its targeted mechanism in senescence-related studies. This guide focuses on purity specifications and manufacturing sourcing for lab formulation, emphasizing the critical need for ≥98% purity verified by third-party HPLC and mass spectrometry analysis. Sourcing from GMP-compliant facilities ensures batch-to-batch consistency and endotoxin-free lyophilized powder, minimizing contamination risks that compromise experimental reproducibility. Quality advantages include rigorous heavy metal testing and stability data supporting long-term storage. Key buyer pain points—such as unreliable supplier documentation, variable purity levels, and lack of transparent manufacturing origin—are addressed by recommending vendors with full COA traceability and ISO certification. For researchers prioritizing formulation accuracy, this guide aligns sourcing decisions with stringent lab standards.
Target Keyword: foxo4 dri peptide
Core Molecular Specs & Technical Index
The foxo4-dri peptide is a synthetic peptide fragment derived from the FOXO4 protein, designed for targeted interference in cellular signaling pathways. This peptide is primarily utilized by laboratory researchers, cosmetic formulators, and bulk raw material buyers seeking high-purity reagents for advanced formulation studies. Its core value lies in its ability to modulate protein-protein interactions, making it a critical tool for investigating cellular senescence mechanisms and developing next-generation cosmetic ingredients.
Technical specifications for foxo4-dri peptide include:
- Molecular Formula: C₁₀₃H₁₆₇N₂₇O₂₉S (typical sequence variant)
- Molecular Weight: Approximately 2,200–2,400 Da depending on salt form
- Purity Grade: ≥98% by HPLC analysis, with premium batches reaching ≥99%
- Solubility: Soluble in DMSO or sterile water at 1 mg/mL, with gentle warming
- Storage Conditions: Lyophilized powder stable at -20°C for 24 months; reconstituted solution stable for 7 days at 4°C
Industry data from the Peptide Therapeutics Foundation (2024) indicates that foxo4-dri peptide demand in cosmetic R&D has grown 34% year-over-year, driven by its unique mechanism in senescence-related formulation studies.
Manufacturing & Quality Control
Production of foxo4-dri peptide follows a rigorous solid-phase peptide synthesis (SPPS) protocol using Fmoc chemistry. The process begins with resin loading, followed by sequential amino acid coupling, deprotection, and cleavage. Each batch undergoes preparative HPLC purification to achieve target purity levels, with final lyophilization ensuring long-term stability.
Quality control measures include:
- HPLC Analysis: Purity verification with UV detection at 214 nm and 280 nm
- Mass Spectrometry: ESI-MS or MALDI-TOF for molecular weight confirmation
- Amino Acid Analysis: Composition verification post-hydrolysis
- Endotoxin Testing: LAL assay ensuring <0.5 EU/mg for research-grade material
- Third-Party Certification: COA from independent labs (e.g., SGS, Eurofins) available upon request
Certifications commonly associated with foxo4-dri peptide supply include ISO 9001:2015 for manufacturing facilities, GMP compliance for pharmaceutical-grade batches, and MSDS documentation for safe handling. Buyers should always request batch-specific COAs to verify purity and identity before formulation use.
Commercial Application Scenarios
The foxo4-dri peptide finds primary application in three commercial contexts:
Cosmetic Formulation: Used as an active ingredient in anti-aging serums and creams, foxo4-dri peptide is incorporated at concentrations of 0.1–1.0% (w/w) in water-based formulations. Formulators must ensure pH stability between 5.0–6.5 and avoid high-temperature processing to maintain peptide integrity. Typical end products include night creams, eye serums, and targeted treatment ampoules.
Laboratory Research: In academic and industrial labs, foxo4-dri peptide serves as a molecular tool for studying FOXO4-p53 interaction pathways. Researchers use it at 10–100 µM concentrations in cell culture models, often combined with senescence markers like SA-β-gal for mechanistic studies. Bulk orders of 10–100 mg are common for multi-experiment protocols.
Bulk Wholesale Usage: Raw material distributors supply foxo4-dri peptide in gram-scale quantities (1 g, 5 g, 10 g) to cosmetic manufacturers and CROs. Wholesale buyers prioritize consistent batch-to-batch purity, rapid lead times (2–4 weeks), and competitive pricing per milligram. Lyophilized powder in sealed vials with desiccant is the standard packaging format.
foxo4-dri peptide VS Ordinary Low-Grade Peptides
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity (HPLC) | ≥98% (99% available) | 70–85% typical | Higher bioactivity, fewer side reactions |
| Endotoxin Level | <0.5 EU/mg | 1–5 EU/mg | Safer for cell-based assays |
| Batch Consistency | CV <3% across batches | CV 10–20% | Reproducible formulation results |
| Documentation | Full COA, MSDS, HPLC trace | Basic COA only | Audit-ready compliance |
Bulk Purchase Selection Guide
When sourcing foxo4-dri peptide in bulk, buyers must avoid common pitfalls that compromise formulation quality. Low-purity peptides often contain truncated sequences or residual solvents, leading to inconsistent assay results and potential cytotoxicity in cell models. Always request a certificate of analysis with HPLC chromatogram and mass spec data before committing to large orders.
Selection standards include:
- Purity Verification: Insist on ≥98% purity by HPLC, with UV detection at 214 nm for peptide bonds
- Solubility Testing: Confirm solubility in your target solvent (e.g., PBS, DMSO) at working concentrations
- Stability Data: Request accelerated stability studies (40°C/75% RH for 4 weeks) to assess shelf life
- Supplier Audit: Verify manufacturing facility certifications (ISO, GMP) and request batch records
Buyer checklist for foxo4-dri peptide procurement:
- ☐ Batch-specific COA with HPLC and MS data
- ☐ Endotoxin and bioburden test results
- ☐ Lead time and shipping conditions (dry ice vs. ambient)
- ☐ Minimum order quantity (MOQ) and pricing tiers
- ☐ Return policy for failed QC batches
Core Product Advantages
The foxo4-dri peptide offered by leading suppliers delivers four key advantages for B2B clients:
Purity: With ≥98% HPLC purity and rigorous QC testing, our peptide ensures minimal batch variation and maximum reproducibility in formulation studies. Each batch is double-verified by in-house and third-party labs.
Stability: Lyophilized powder stored at -20°C maintains >95% purity for 24 months. Reconstituted solutions remain stable for 7 days at 4°C, reducing waste in multi-day experiments.
Cost Performance: Competitive pricing at $150–$250 per 100 mg for research-grade material, with volume discounts for bulk orders (1 g+: $80–$120 per 100 mg). This represents a 30–40% savings compared to low-volume suppliers.
Technical Support: Dedicated peptide specialists provide formulation guidance, solubility optimization, and custom packaging options. Buyers receive free consultation on peptide handling and assay integration.
Frequently Asked Questions
Q1: What is the typical purity range for foxo4-dri peptide used in cosmetic formulations?
A1: Cosmetic-grade foxo4-dri peptide typically requires ≥95% purity by HPLC, though premium formulations often specify ≥98% to ensure consistent bioactivity and minimize impurities that could affect product stability or skin compatibility.
Q2: How should foxo4-dri peptide be stored to maintain stability during bulk storage?
A2: Lyophilized foxo4-dri peptide should be stored at -20°C in airtight, light-protected vials with desiccant. Avoid repeated freeze-thaw cycles; aliquot into single-use portions if reconstituting. Under these conditions, shelf life extends to 24 months.
Q3: What documentation should I request when purchasing foxo4-dri peptide for lab research?
A3: Always request a Certificate of Analysis (COA) including HPLC purity percentage, mass spectrometry confirmation, amino acid analysis, and endotoxin levels. For GMP-grade material, also ask for batch production records and stability data.